Spectral Med Inc (EDT.TO) has seen notable price movements this week following updates on its PMA application.
This week, Spectral Med Inc (EDT.TO) closed at C$1.17, a daily increase of 3.60%. However, it has declined by 7.26% over the past week. The company is still working through the complexities of regulatory approvals and market performance.
Advertisement
Spectral Med Inc
EDT.TO
EDT.TO
Spectral Med Inc
WealthAwesomeMarket cap
$337.59M
52W high
$1.65
52W low
$1.03
1W change
-7.26%
Beta
0.18
Analyst Price Targets
Based on analyst covering EDT · as of Sep 17, 2026
Wall Street analysts forecast EDT stock price to rise 173.9% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$3.15
+173.9% Upside
Current Price
C$1.15
Last close
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on EDT's historical volatility
30-Day Vol
41.8%
Annualized
90-Day Vol
31.0%
Annualized
Trend (90d)
-50.0%
Annualized drift
90d Mean
C$0.96
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$1.08 | C$0.94 – C$1.25 |
| 60 trading days | C$1.02 | C$0.83 – C$1.25 |
| 90 trading days | C$0.96 | C$0.75 – C$1.23 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Advertisement
Investor takeaway: Investors should consider the implications of the recent FDA meeting and the company's financial performance when evaluating the stock's long-term potential.
C$1.17 Closing Price
Spectral Med's stock has fluctuated between C$1.03 and C$1.65 over the past year, showing a 23% movement within its 52-week range.
Bull case
Analysts are optimistic, with an average target of C$3.15, indicating significant upside potential. Recent clarity from the FDA regarding the PMA application adds to this positive outlook.
Bear case
On the flip side, the company's negative return on equity and recent price performance may raise concerns about its financial stability and growth prospects.
Weekly Price Action
Spectral Med Inc (EDT.TO) closed at C$1.17 on Friday, marking a daily increase of 3.60%. Despite this, the stock faced a tough week with a decline of 7.26% and a more significant drop of 14.81% over the past month. Year-to-date, the stock is down 16.67%, reflecting ongoing market challenges.
Recent Company News
Advertisement
While there were no major news releases this week, recent headlines have highlighted important developments for Spectral Medical. On September 11, 2026, the company provided an update after its in-person FDA 100-day meeting regarding the PMA application for PMX. The FDA did not request an additional clinical trial, which clarifies the information needed to advance the review process. This positive feedback could boost future stock performance.
Technical Picture
From a technical perspective, Spectral Med Inc is trading below its 50-day moving average of C$1.33 and its 200-day moving average of C$1.35, indicating bearish momentum in the short to medium term. The stock's 52-week range is between C$1.03 and C$1.65, suggesting it is currently at 23% of its range. The beta of 0.18 indicates lower volatility compared to the market, which may appeal to risk-averse investors.
Insider Activity
No recent insider activity has been reported for Spectral Med Inc, which may suggest a lack of significant changes in ownership or confidence among current shareholders.
Conclusion
In summary, Spectral Med Inc (EDT.TO) closed at C$1.17, reflecting a 3.60% increase for the day, despite a challenging week. Investors should keep an eye on the company's regulatory progress and financial results as they assess its potential moving forward.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
